We are always looking for ways to enable the commercialization of Cell-based Therapy and Technology. The ultimate success of the field is dependent on the convergence of several technology fields, ... More
RoosterBio participated in the annual Tissue Engineering and Regenerative Medicine International Society’s Annual Meeting of the Americas chapter (or TERMIS-AM for short) in Dec 2014. You can find a lot ... More
A “Golden Age” is defined as a period of time in a field where “great tasks are accomplished.” The ancient Greek philosopher Hesiod initially coined this phrase, and I think ... More
We blogged recently about Mesenchymal Stem/Stromal Cell (MSC) Misconceptions that are holding the translational cell therapy field back, as identified by Donald Phinney and Luc Sensebé. Since we have come ... More
We blogged several months ago about bottlenecks in the bioprocessing of Mesenchymal Stem Cells that are impeding their clinical translation. While the development of robust and scalable manufacturing methods, reduced ... More
Mesenchymal stem cells (MSCs) aggregated into three-dimensional (3D) cellular spheroids are a potent configuration for cell therapy and tissue engineering research and product development (5), and cellular spheroids are a ... More
Extreme cellular stress can trigger senescence, a mechanism protecting against malignant cell transformation. Adapted from: Kovacic J C et al. Circulation. 2011;123:1650-1660 We’ve mentioned several times on this blog how standardization of materials, ... More
In the body, MSCs are known to home to sites of acute injury and inflammation and migrate to tumors in response to tumor secretion of growth factors, cytokines, and extracellular ... More
Mesenchymal Stem Cells (MSCs) are widely studied in academic circles and an attractive cell source for clinical applications. MSCs not only possess the ability to self-renew and differentiate to a number ... More
Everyone at RoosterBio is extremely excited to be launching our company, shipping our first products, and interacting with tissue engineers, cell therapists, synthetic biologists, and our customers to learn about ... More
